Clinical Trials in Pittsburgh

Showing 9221-9240 of 21,047 trials

Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury

NCT04877847

Multi-center randomized trial to assess the safety and performance of low-frequency therapeutic ultrasound for maintaining renal function after contrast exposure.

Contrast-induced NephropathyChronic Kidney Diseases

Sonogenix2 participantsStarted Sep 2021

Detroit, Michigan, United States • Petoskey, Michigan, United States • Pittsburgh, Pennsylvania, United States +1 more locations

RECRUITINGPhase 2< 1 mile

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT04920617

This is a Phase 2b, randomized, open label study to assess the safety and efficacy of DPX-Survivac and pembrolizumab, with and without low-dose cyclophosphamide (CPA) in subjects with relapsed or refractory DLBCL.

Relapsed Diffuse Large B-cell LymphomaRefractory Diffuse Large B-cell Lymphoma

ImmunoVaccine Technologies, Inc. (IMV Inc.)102 participantsStarted Jun 2021

Fountain Valley, California, United States • Boca Raton, Florida, United States • Hollywood, Florida, United States +47 more locations

Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Find Trials by Condition in Pittsburgh

A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma

Point-of-Care Immunoassay for Detection of Bacterial Sinusitis

Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease

MCI: CPAP Treatment of OSA (Memories2)

A Study of t:Slim X2 With Control-IQ Technology

PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine.

N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma

N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma

N99-02: Melphalan and Buthionine Sulfoximine

A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa

A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS)

Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)

Bioequivalence Study of Tiotropium Bromide Inhalation Powder

Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis

Ganaxolone Treatment in Children With Fragile X Syndrome